Opthea Limited Issues New Contractor Options

TipRanksApr 14 23:17 ET

Owning 39% Shares,institutional Owners Seem Interested in Opthea Limited (ASX:OPT),

Yahoo FinanceApr 12 16:49 ET

Opthea Hires New VP to Advance Retinal Therapies

TipRanksApr 8 18:57 ET

Opthea Appoints John Han, PharmD, as VP Medical Affairs

MELBOURNE, Australia and PRINCETON, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent

GlobeNewswireApr 8 18:42 ET

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Ultragenyx Pharmaceutical (RARE) and Opthea Limited Sponsored ADR (OPT)

TipRanksApr 8 03:40 ET

Opthea Limited Foresees Visionary Breakthroughs

TipRanksApr 4 19:37 ET